Eleven Biotherapeutics (EBIO) – FDA
-
Eleven Biotherapeutics (EBIO) Says New Preclinical Data Highlighting its DeBouganin Program to be Presented at AACR
-
Eleven Biotherapeutics (EBIO) Reports Completed Enrollment in VISTA Phase 3 Registration Trial of Vicinium
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to EBIO Stock Lookup